company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5381000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2132000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1028000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2633000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2633000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,246000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2667000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2913000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2913000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-108000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,170000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7415000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7415000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1655000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,508000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5108000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-144000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-144000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1451000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4010000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,90000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2667000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-18000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-18000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-197000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8408000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1066000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3916000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1925000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1501000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1501000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-350000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2282000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2436000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2436000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,915000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q1,2011-01-01,2011-03-31,2012-05-21 11:01:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1097000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7401000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,286000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3540000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3540000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9280000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9280000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9280000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-103000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5634000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1895000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7810000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,320000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5111000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5111000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,50000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,79000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5059000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12576000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1958000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7241000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1183000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4556000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4555000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-450000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3261000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2907000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2907000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,47000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1619000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10151000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4634000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,203000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1771000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3541000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3541000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,639000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2955000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-40000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q1,2012-01-01,2012-03-31,2012-05-21 11:01:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10150000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1382000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,638000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3295000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4833000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4833000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7861000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,347000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2955000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5253000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,393000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16496000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16496000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2676000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2356000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5327000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6131000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6131000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6163000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-347000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5816000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5816000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-319000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30523000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30523000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5328000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11701000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5241000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8249000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8249000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2193000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12375000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,5302000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15484000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15484000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7235000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14394000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,368000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1492000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5457000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7074000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7074000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-299000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6973000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:11:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11594000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1333000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1935000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8209000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8209000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-389000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10210000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9821000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9821000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1612000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22910000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7484000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7492000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7916000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7916000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4554000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4554000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-814000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-240000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13791000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1005000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13342000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13342000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,872000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16891000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2290000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14601000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14601000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,54000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4555000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4555000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-602000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,240000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4195000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,53026000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-24001000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25688000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25688000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15642000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25865000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3222000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5701000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16939000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16939000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3414000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1375000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17940000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,395000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16986000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16976000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3377000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21043000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,346000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,121000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2294000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9800000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8482000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22332000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,789000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21543000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21543000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22904000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2059000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1730000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22575000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22575000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7450000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42685000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-341000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,91000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19388000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4951000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18596000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18596000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11395000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11395000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11395000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-647000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,34806000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2099000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5710000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41968000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41978000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11987000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46433000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,234000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29168000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-554000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17582000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1133000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-138000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8648000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8510000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8510000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-15000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10220000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 19:46:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,428000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66845000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38603000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,645000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27102000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27102000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-882000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-882000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-882000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,62000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,40000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3141000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43203000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43203000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,813000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16032000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,375000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22615000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,296000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-42662000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7925000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11797000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11797000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1995000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1995000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1995000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,225000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,639000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,864000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,864000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-882000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13810000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-803000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24078000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3181000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2637000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23230000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23230000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2741000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2741000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2741000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,81375000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-40000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1399000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41374000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41374000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-372000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15031000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6106000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,209000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9844000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1867000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17595000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17595000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2683000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2683000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2683000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-756000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9244000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9244000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,634000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 17:25:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14175000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,222000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5273000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4953000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14206000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14206000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3894000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3894000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3894000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2387000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9545000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29227000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29227000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,208000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13591000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5619000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9754000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9754000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-467000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-467000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-467000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-321000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4626000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3377000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7682000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7682000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,923000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1616000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,211000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5747000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10597000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14097000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14097000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-169000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-169000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25437000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-8209000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,260000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17488000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17488000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2162000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5384000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,373000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-206000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12283000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12283000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,218000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,218000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,218000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1730000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-693000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2620000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,451000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8048000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8048000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-622000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4639000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2017.0,Q1,2017-01-01,2017-03-31,2018-05-16 17:03:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,47000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20946000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,296000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13526000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2629000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9751000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9751000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-164000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-164000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-164000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-749000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4000000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,688000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3939000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3939000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,40000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5936000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q1,2019-01-01,2019-03-31,2020-06-23 18:56:00+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,174000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,219000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,367000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7453000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2817000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9678000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9678000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-225000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,164000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4002000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1531000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,98000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9612000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6242000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,357000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1224000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,649000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6452000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6452000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1398000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2241000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,850000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,850000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,917000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4706000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-177000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6673000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,410000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12921000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-145000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5978000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5978000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-114000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,5400000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,500000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4633000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5399000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5134000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5134000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-640000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1598000.0
Northwest Biotherapeutics Inc,NWBO,5493002DRWWEOWTT8005,0001072379,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1015000.0
